Medline ® Abstract for Reference 33
of 'Management of acute chemotherapy-related diarrhea'
Quantifying the 'hidden' lactose in drugs used for the treatment of gastrointestinal conditions.
Eadala P, Waud JP, Matthews SB, Green JT, Campbell AK
Aliment Pharmacol Ther. 2009 Mar;29(6):677-87.
BACKGROUND: Lactose intolerance affects 70% of the world population and may result in abdominal and systemic symptoms. Treatment focuses predominantly on the dietary restriction of food products containing lactose. Lactose is the most common form of excipient used in drug formulations and may be overlooked when advising these patients.
AIM: To identify and quantify the amount of lactose in medications used for the treatment of gastrointestinal disorders and to identify 'lactose-free' preparations.
METHODS: Medications used for the treatment of gastrointestinal disorders were identified from the British National Formulary (BNF). Their formulation including excipients was obtained from the Medicines Compendium. The lactose content and quantity in selected medications was measured using high-performance liquid chromatography (HPLC).
RESULTS: A wide range of medications prescribed for the treatment of gastrointestinal conditions contain lactose. We have quantified the lactosecontent in a selection of medications using HPLC. Lactose is present in amounts that may contribute towards symptoms. Lactose-free alternatives were also identified.
CONCLUSIONS: Lactose is present in a range of medications and may contribute towards symptoms. This may not be recognized by the prescribing doctor as excipients are not listed in the BNF, and the quantity of lactose is not listed on the label or in the accompanying manufacturer's leaflet.
Department of Gastroenterology, Llandough Hospital, Cardiff CF642XX, UK. email@example.com